Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 205   Next >
 
6.  
Fluorouracil chemotherapy: the My5-FU assay for guiding dose adjustment. 2014 Dec 10. NGC:010621
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. 2012 Jul (revised 2014 Oct). NGC:010590
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
8.  
Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. 2003 Sep (revised 2014 Sep). NGC:010556
National Collaborating Centre for Mental Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Dyspepsia and gastro-oesophageal reflux disease. Investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both. 2004 Aug (addendum released 2005 Jun; revised 2014 Sep). NGC:010554
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Diagnosis and management of type 2 diabetes mellitus in adults. 1996 Mar (revised 2014 Jul). NGC:010548
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
12.  
13.  
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 1998 Nov 1 (revised 2014 June 10). NGC:010432
American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Professional Association. View all guidelines by the developer(s)
14.  
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. 2012 May (revised 2014 May). NGC:010422
American Urological Association Education and Research, Inc. - Medical Specialty Society; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction - Professional Association. View all guidelines by the developer(s)
15.  
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 1998 Dec 1 (revised 2014 May 1). NGC:010355
Department of Health and Human Services (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
16.  
Venous thromboembolism (VTE). 1998 Jun (revised 2014 May). NGC:010400
University of Michigan Health System - Academic Institution. View all guidelines by the developer(s)
17.  
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. 2012 Feb (revised 2014 Apr). NGC:010329
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
18.  
19.  
20.  
Management of chronic kidney disease. 2014 Mar. NGC:010323
University of Michigan Health System - Academic Institution. View all guidelines by the developer(s)
1-20 of 205   Next >